Five-Year Mortality among Survivors of Coronary Artery Bypass Graft Surgery: A Retrospective Study from a Tertiary

Eduardo Martelli Moreira1,2, Bernadette Cunha Waldvogel3, Eduardo Bello Martins1,4

  • 1Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil.

Insights

This study found moderate five-year mortality rates after Coronary Artery Bypass Graft (CABG) surgery in Brazil. Key risk factors for death include age, diabetes, and heart function, informing better patient care.

Area of Science:

  • Cardiovascular Surgery Outcomes
  • Public Health Policy
  • Clinical Practice Guidelines

Background:

  • Limited long-term outcome data for Coronary Artery Bypass Graft (CABG) surgery in Brazil.
  • Essential data for informing public health policies and clinical practice.
  • Need for comprehensive mortality analysis post-CABG.

Purpose of the Study:

  • Estimate five-year all-cause and cause-specific mortality rates in CABG patients.
  • Identify significant risk factors associated with mortality post-CABG.
  • Provide data to guide clinical decision-making and public health strategies.

Main Methods:

  • Retrospective analysis of 6,933 patients undergoing CABG (2007-2018).
  • Utilized government databases for mortality data retrieval up to 2018.
  • Statistical significance level set at 5% for analysis.

Main Results:

  • Cohort: 4,854 men (72%), median age 63 years; 43% with diabetes, 29% with chronic kidney disease.
  • Overall 5-year all-cause mortality: 12.9%; cardiovascular mortality: 5.7%.
  • Leading causes of cardiovascular death: ischemic heart disease (57.3%) and cerebrovascular disease (16.6%).

Conclusions:

  • Patients undergoing CABG at a tertiary center show moderate five-year mortality rates.
  • Identified prognostic factors include age, diabetes, kidney function, lipid profile, cardiac function, and surgical approach.
  • Findings support risk stratification and improved postoperative management strategies for CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...